News & Updates

Show Multimedia Only
Once- on par with twice-daily cilostazol–Ginkgo biloba combo in peripheral arterial disease

Once- on par with twice-daily cilostazol–Ginkgo biloba combo in peripheral arterial disease

23 Apr 2022

In the treatment of ischemic symptoms associated with peripheral arterial disease, the use of once-daily SID142 appears to be as good as twice-daily Renexin while having a favourable safety profile, as shown in a phase III study.

23 Apr 2022